InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Stewart Christopher P., Chief Financial Officer. Director active across 3 companies, notably Bionano Genomics, Inc. Aggregated, 5 disclosures have been logged. The latest transaction was disclosed on 13 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
€32,37160,000 shares@ €0.53950.20% mcap59.4% of flow
Common Stock
SEC:0001209191-22-029459:0·
€11,08322,500 shares@ €0.4926100.0% of flow
Common Stock
SEC:0001209191-21-066283·
€11,08322,500 shares@ €0.49260.067% mcap20.3% of flow
Common Stock
SEC:0001209191-21-066283:0·
€11,48225,000 shares@ €0.4593100.0% of flow
Common Stock
SEC:0001209191-21-036254·
€11,48225,000 shares@ €0.45930.070% mcap50.0% of flow
Common Stock
SEC:0001209191-21-036254:0·
5 of 5 declarations
About Stewart Christopher P.
Christopher P. Stewart is the Chief Financial Officer at Bionano Genomics, Inc. He is responsible for the financial management of the company, including budgeting and performance analysis. With extensive experience in finance, he plays a key role in financial strategy and decision-making. His commitment to transparency and compliance is essential for Bionano Genomics' success.
